Bahamdain, F. O. “Retracted: Effect of Dolutegravir on Plasma Glucose Among Human Immunodeficiency Virus Patients in a Community Health Center Setting”. International Journal Of Community Medicine And Public Health, vol. 9, no. 3, Feb. 2022, pp. 1178-82, doi:10.18203/2394-6040.ijcmph20220673.